# Drug-Drug Interaction Study of Rucaparib, Rosuvastatin and Oral Contraceptives

> **NCT03954366** · PHASE1 · COMPLETED · sponsor: **pharmaand GmbH** · enrollment: 36 (actual)

## Conditions studied

- Neoplasms

## Interventions

- **DRUG:** Rucaparib
- **DRUG:** Rosuvastatin
- **DRUG:** Oral Contraceptives

## Key facts

- **NCT ID:** NCT03954366
- **Lead sponsor:** pharmaand GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-25
- **Primary completion:** 2019-12-06
- **Final completion:** 2021-06-09
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2023-06-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03954366

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03954366, "Drug-Drug Interaction Study of Rucaparib, Rosuvastatin and Oral Contraceptives". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03954366. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*